Drugging the ‘Undruggable’; The Discovery of AMG 510, a First-in-Class Covalent Inhibitor of KRASG12C Read more about Drugging the ‘Undruggable’; The Discovery of AMG 510, a First-in-Class Covalent Inhibitor of KRASG12C
Rational design of Kinase inhibitors in autoimmune diseases. The TYK2 story Read more about Rational design of Kinase inhibitors in autoimmune diseases. The TYK2 story
Applying Medicinal Chemistry Principles to the Discovery of Linkers, Payloads and Antibody Drug Conjugates fro the Treatment of Cancer Read more about Applying Medicinal Chemistry Principles to the Discovery of Linkers, Payloads and Antibody Drug Conjugates fro the Treatment of Cancer
Overview of Pharmaceutical Development – From Discovery to Market Read more about Overview of Pharmaceutical Development – From Discovery to Market
Part 1: Fragment-Based Drug Discovery: Concepts and Case Studies; Part 2: Non-Bonding Sulfur Interactions in Drug Design Read more about Part 1: Fragment-Based Drug Discovery: Concepts and Case Studies; Part 2: Non-Bonding Sulfur Interactions in Drug Design
Barriers and pitfalls in small molecule drug discovery Read more about Barriers and pitfalls in small molecule drug discovery
Targeting IDO1 in Immuno-Oncology: Discovery of GS-4361 Read more about Targeting IDO1 in Immuno-Oncology: Discovery of GS-4361
Development of allosteric modulators of alpha7 nicotinic acetylcholine receptors Read more about Development of allosteric modulators of alpha7 nicotinic acetylcholine receptors